Date Filed | Type | Description |
08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
SC 13G/A
| SHEN NEIL NANPENG reports a 0.2% stake in Futu Holdings Limited |
02/14/2022 |
SC 13G/A
| SHEN NEIL NANPENG reports a 0% stake in MOLECULAR DATA INC. |
02/14/2022 |
SC 13G/A
| SHEN NEIL NANPENG reports a 0.7% stake in Dada Nexus Limited |
11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/12/2021 |
SC 13G/A
| SHEN NEIL NANPENG reports a 11.1% stake in MOLECULAR DATA INC. |
11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2020 |
SC 13G
| SHEN NEIL NANPENG reports a 14.3% stake in MOLECULAR DATA INC. |
02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/01/2018 |
4
| SC China Venture VI Management, L.P. (10% Owner) has filed a Form 4 on ARMO BioSciences, Inc.
Txns:
| Converted 809,800 shares
@ $0 Converted 809,800 preferred shares
@ $0 |
|
01/25/2018 |
3
| SC China Venture VI Management, L.P. (10% Owner) has filed a Form 3 on ARMO BioSciences, Inc. |
11/13/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
02/10/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
11/14/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
|